Li Hongzhong, a vice chairman of the National People's Congress (NPC) Standing Committee, addressed the fourth session of the fourth NPC on Thursday, delivering explanatory remarks on three draft laws ...
Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
Claude Code, Anthropic's AI agent coding tool, now features a remote control feature that allows tasks started on a terminal to be taken over by a smartphone. New in Claude Code: Remote Control. Kick ...
Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...
Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...
March 21, 2026: We're back on our tiny barge on the grand old hunt for new Meme Seas codes. What are the new Meme Sea codes? When taking on an ocean of the internet's most popular memes with a One ...
March 21, 2026: Back for another weekend? If you're new to the latest update, we have a few new [🦖UPD 10] King Legacy codes for you to redeem down below. Looking for new King Legacy codes to speed up ...
Scammers are sending fake calendar “renewal” notices impersonating Malwarebytes to trick victims into calling a fake billing number.
Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results